Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | ACLY | P53396 | 2/20 | 0.49 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | PTGDR | Q13258 | 1/20 | 0.43 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6815943 | 0.86 | LMNA (0.56) | LMNAKDM4EKMT2AACLYPTGS2 | |
| SCHEMBL21999631 | 0.85 | ACLY (0.55) | LMNAKDM4EKMT2AACLYPTGS2 | |
| SCHEMBL7334329 | 0.84 | LMNA (0.54) | LMNAKDM4EKMT2AACLYPTGS2 | |
| SCHEMBL15517469 | 0.84 | LMNA (0.53) | LMNAKDM4EKMT2APTGS2MAPT | |
| SCHEMBL10981786 | 0.83 | CYP1A2 (0.45) | LMNAKDM4EKMT2AMAPTALDH1A1 | |
| SCHEMBL5109846 | 0.81 | KMT2A (0.65) | LMNAKDM4EKMT2AACLYPTGS2 | |
| SCHEMBL3349589 | 0.81 | ALDH1A1 (0.46) | LMNAKDM4EKMT2AMAPTALDH1A1 | |
| SCHEMBL6812567 | 0.80 | LMNA (0.50) | LMNAKDM4EKMT2AACLYPTGS2 | |
| SCHEMBL7329205 | 0.80 | LMNA (0.50) | LMNAKDM4EKMT2AACLYPTGS2 | |
| SCHEMBL25528281 | 0.79 | LMNA (0.56) | LMNAKDM4EKMT2APTGS2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11078150-B2 | Preparation method for chlorophenoxycarboxylate | SHANDONG RAINBOW BIOTECH CO., LTD. (CN) | 2021-08-03 | — | — | US | disclosed |
| US-20210002201-A1 | PREPARATION METHOD FOR CHLOROPHENOXYCARBOXYLATE | SHANDONG RAINBOW BIOTECH CO., LTD. (CN) | 2021-01-07 | — | — | US | disclosed |
| WO-2019179291-A2 | PREPARATION METHOD FOR CHLOROPHENOXYCARBOXYLATE | 山东润博生物科技有限公司 | 2019-09-26 | — | — | WO | disclosed |
| WO-2019179288-A2 | PREPARATION METHOD FOR CHLOROPHENOXYCARBOXYLATE | 山东润博生物科技有限公司 | 2019-09-26 | — | — | WO | disclosed |
| CN-108947840-A | A kind of preparation method of chlorobenzene oxycarboxylic acid ester | 山东润博生物科技有限公司 | 2018-12-07 | — | — | CN | disclosed |
| CN-108947820-A | Preparation method of chlorinated phenoxy carboxylic ester | 山东润博生物科技有限公司 | 2018-12-07 | — | — | CN | disclosed |
| CN-108947807-A | A kind of preparation method of chlorobenzene oxycarboxylic acid amine salt | 山东润博生物科技有限公司 | 2018-12-07 | — | — | CN | disclosed |
| CN-108947806-A | A kind of preparation method of chlorobenzene oxycarboxylic acid amine salt | 山东润博生物科技有限公司 | 2018-12-07 | — | — | CN | disclosed |
| EP-1155010-A1 | ACETAMIDO ACETONITRILE DERIVATIVES AS INHIBITORS OF CATHEPSIN L AND/OR CATHEPSIN S | AstraZeneca AB (SE) | 2001-11-21 | — | — | EP | disclosed |
| WO-2000049007-A1 | ACETAMIDO ACETONITRILE DERIVATIVES AS INHIBITORS OF CATHEPSIN L AND/OR CATHEPSIN S | ASTRAZENECA AB (SE) | 2000-08-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210002201-A1 | PREPARATION METHOD FOR CHLOROPHENOXYCARBOXYLATE | CBLB, CBL, CBLC | LMNA 2077/4885KDM4E 320/4885KMT2A 535/4885 |
| US-11078150-B2 | Preparation method for chlorophenoxycarboxylate | CBLB, CBL, CBLC | LMNA 2077/4885KDM4E 320/4885KMT2A 535/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.